Under the Radar: In conversation with the MD of Singapore, Malaysia and Brunei at MSD; MSD’s positioning across geographical markets; Global pharmaceutical market to grow to US$2.4t in 2029; The impact of the COVID-19 pandemic on the industry; MSD’s new facilities in Singapore; Views on Singapore’s business operating environment; Focus on health literacy and health equity

Your Way Home with Hongbin Jeong · Mar 27, 2023 · 15m

Founded in 1891, MSD is a leading science and technology company in healthcare, life sciences and pharmaceuticals. The company is among the top 10 globally with a revenue of US$59.3 billion in 2022. With the global pharmaceutical industry expected to grow to around US$2.4 trillion in 2029 according to Fortune Business insights, we want to find out what’s next for the company, particularly here in Singapore. On that note, MSD announced the opening of two manufacturing facilities to produce vaccines and biologics in Singapore back in October last year. But what is the status right now, and what…